In addition to their immune suppressive function, they may be a target for antibody dependent cellular cytotoxicity (ADCC) by ipilimumab due to their high expression levels of CTLA-4 that make Tregs sentinels for ICI-mediated anti-tumor responses. This evidence concerns the gene CTLA4 and neoplasm.